2016 reflections on the favorable cost-benefit of lung cancer screening

  • Print
  • Connect
  • Email
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
By Bruce S. Pyenson, Gabriela Dieguez | 23 May 2016

The variation of results in cost-benefit analyses for particular treatments can be bewildering to medical experts unfamiliar with real-world healthcare financing. This article gives a basic background on cost-benefit analyses in healthcare, using lung cancer screening as a case study.

This article was originally published in the Annals of Translational Medicine.